Last data update: Jul 06, 2022 . (Total: 37202 Documents since 2020)
Records 1-5 (of 5 Records)
|Query Trace: IFNA2[original query]>>IFNA2[Gene]|
| Differentially expressed immune response genes in COVID-19 patients based on disease severity.
Li Shasha, et al. Aging 2021 3 0.
| Type-I Interferon assessment in 45 minutes using the FilmArray PCR platform in SARS-CoV-2 and other viral infections.
Mommert Marine, et al. European journal of immunology 2020 12 0.
| JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.
Stebbing Justin, et al. Science advances 2020 11 0.
| Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience.
Pereda Ricardo, et al. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2020 9 0. (9) 438-442
| Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Yao Zhixian, et al. Aging 2020 5 0.
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.